"Impetigo" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A common superficial bacterial infection caused by STAPHYLOCOCCUS AUREUS or group A beta-hemolytic streptococci. Characteristics include pustular lesions that rupture and discharge a thin, amber-colored fluid that dries and forms a crust. This condition is commonly located on the face, especially about the mouth and nose.
Descriptor ID |
D007169
|
MeSH Number(s) |
C01.252.410.868.820.504 C01.252.410.890.485 C01.252.825.770.360 C01.539.800.720.770.360 C17.800.838.765.770.360
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Impetigo".
Below are MeSH descriptors whose meaning is more specific than "Impetigo".
This graph shows the total number of publications written about "Impetigo" by people in this website by year, and whether "Impetigo" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 1 | 1 |
2015 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2018 | 4 | 0 | 4 |
2019 | 4 | 0 | 4 |
2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Impetigo" by people in Profiles.
-
A case of goggle-mask-related impetigo at the time of the COVID-19 pandemic. Dermatol Ther. 2020 Jul; 33(4):e13636.
-
Prevalence of Scabies and Impetigo 3 Years After Mass Drug Administration With Ivermectin and Azithromycin. Clin Infect Dis. 2020 04 10; 70(8):1591-1595.
-
Prevalence of scabies and impetigo in the Solomon Islands: a school survey. BMC Infect Dis. 2019 Sep 13; 19(1):803.
-
Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial. Lancet Infect Dis. 2019 05; 19(5):510-518.
-
Ozenoxacin: a review of preclinical and clinical efficacy. Expert Rev Anti Infect Ther. 2019 03; 17(3):159-168.
-
Treatment, prevention and public health management of impetigo, scabies, crusted scabies and fungal skin infections in endemic populations: a systematic review. Trop Med Int Health. 2019 03; 24(3):280-293.
-
Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Pooled Analysis of Phase 3 Clinical Trials. J Drugs Dermatol. 2018 Oct 01; 17(10):1051-1057.
-
Scabies and risk of skin sores in remote Australian Aboriginal communities: A self-controlled case series study. PLoS Negl Trop Dis. 2018 07; 12(7):e0006668.
-
A review of the antibacterial activity of ozenoxacin. Future Microbiol. 2018 05 01; 13:1-2.
-
Comparative in vitro antibacterial activity of ozenoxacin against Gram-positive clinical isolates. Future Microbiol. 2018 05 01; 13:3-19.